Choosing the right stem cell source directly influences treatment results. Adipose tissue, bone marrow, and donor cells all have roles—understanding their strengths guides personalised care.
MSC Abundance
Adipose tissue contains 100–1000 times more MSCs per millilitre than bone marrow. This high yield means smaller harvests produce ample cell numbers for therapy.
Aging Resilience
Adipose MSCs retain telomere length and differentiation capacity longer than bone marrow MSCs, particularly in patients over 50.
Convenience and Safety
Fat harvesting is outpatient and minimally invasive, whereas bone marrow aspiration can be more uncomfortable and yields fewer cells. Autologous adipose cells also eliminate donor matching and rejection risks.
Comparing Autologous vs Donor Cells
Donor (allogeneic) cells introduce immune considerations and stricter regulatory pathways. Japan’s Class II framework favours autologous adipose-derived MSCs for safety and consistency.
Learn how fat-derived cells work in practice by combining this guide with “What Is a CPC?” and “Stem Cell Therapy Results by Month,” then speak with our physicians about your eligibility.
Frequently Asked Questions
Why choose adipose-derived stem cells?
They provide higher yields, age more slowly, and require only a minimally invasive collection procedure.
Do bone marrow stem cells work better?
Bone marrow cells can be effective, but yield and comfort often favour adipose cells for orthopedic and longevity goals.
How long do adipose stem cell results last?
Patients typically maintain improvements for 12–36 months, especially with supportive rehabilitation and booster sessions.
Does the harvest hurt?
Adipose harvesting uses local anaesthesia. Mild soreness usually resolves within a few days.
Ready to Learn More?
Schedule a consultation with our specialists to discuss how stem cell therapy can help you. Learn whether adipose stem cells are right for your joint condition.
